DUPAGE COUNTY, Ill. (WGN) — It’s a quiet day in Wheaton, and Jessica Wozniak is in her kitchen, making a cup of tea. The mother of a preschooler is taking advantage of some time to relax, read, and ...
Collaborative trial with Alliance for Clinical Trials in Oncology will evaluate new approaches to increase germline genetic testing among at-risk family members Research will also assess the clinical ...
So it's important to remember that all human beings have a risk of colorectal cancer. About 1 in 23 men will be diagnosed with colorectal cancer and about 1 in 25 women, but about 5 to 10% of those ...
For 10% of colorectal cancer patients, hereditary factors play a role, with higher percentages among younger patients. Research from Radboud University Medical Center and University Hospital Bonn (UKB ...
Everyday Health on MSN
Never too young: A 30-something battles hereditary colon cancer
Wes Hensel had complained to his doctors about occasional rectal bleeding for 4 years. But his gastroenterologist assured him ...
The diagnosis of Lynch syndrome in patients with colorectal cancer has evolved from reliance on clinical criteria to integrated molecular and genetic approaches. Genetic testing strategies typically ...
Colorectal cancer (CRC) arises through a combination of inherited and acquired genetic alterations that disrupt key pathways of DNA repair, cell growth and immune surveillance. Germline variants in ...
GREENSBORO, N.C. (WGHP) — A test in the Triad that can tell if you have an increased chance of breast cancer, ovarian cancer, colon cancer and heart disease, and it’s completely free. “Some people do ...
For years, a diagnosis of colon cancer meant potential surgery followed by a painful round of chemotherapy to kill the remaining cancer cells. One-size-fits-all treatment was normal. A new blood test ...
After surviving three types of cancer and having to face the harsh realities of colorectal and endometrial cancer and basal cell carcinoma, I know just how crucial early detection can be in saving ...
Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announces expanded availability of Precise ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results